Remote Director, Emerging Therapies Medical Affairs

Insightec; United States; Remote; USD 180,000 - 240,000; Full time

Job summary

Insightec is seeking a Director of Medical Affairs – Emerging Therapies to lead medical innovation and strategy across early- and mid-stage programs leveraging the 220KHz FUS platform. The role focuses on scientific rigor, regulatory readiness, and cross-functional collaboration with R&D, market access, and commercial teams.

The leader will drive external engagement with KOLs and scientific leaders, oversee trials and publications, and guide development plans toward timely commercialization of

Qualifications

• Experience leading medical affairs for emerging therapies.
• Strong engagement with KOLs and scientific leaders.
• Experience in clinical development, regulatory submissions, and market access.

Responsibilities

• Develop and lead medical strategy for emerging therapies leveraging the 220KHz FUS platform.
• Collaborate with R&D, regulatory, and commercial to align on portfolio strategy and timelines.
• Oversee clinical trials readiness and execution, including endpoint definition and data generation.
• Lead advisory boards and external collaborations with academic partners and KOLs.
• Drive publications strategy, scientific communications, and podium presence at major congresses.
• Provide medical input for regulatory submissions and labeling; support safety communications.

Skills

Medical affairs leadership

KOL engagement

Clinical development

Strategic planning

Regulatory & compliance

Cross-functional leadership

Evidence generation

Job description

Insightec is seeking a Director of Medical Affairs – Emerging Therapies to lead medical innovation and strategy across early- and mid-stage programs leveraging the 220KHz FUS platform. The role focuses on scientific rigor, regulatory readiness, and cross-functional collaboration with R&D, market access, and commercial teams.

The leader will drive external engagement with KOLs and scientific leaders, oversee trials and publications, and guide development plans toward timely commercialization of